Medicine & Life Sciences

1. HIV 100%
2. Hepacivirus 51%
3. HIV Infections 38%
4. Chronic Hepatitis C 37%
5. Retroviridae Infections 36%
6. Virus Diseases 33%
7. Opportunistic Infections 27%
8. Coronavirus 26%
9. T-Lymphocytes 26%
10. Apoptosis 20%
11. Therapeutics 20%
12. Infections 17%
13. Caspase 8 14%
14. Pharmaceutical Preparations 13%
15. Sofosbuvir 12%
16. Heart-Assist Devices 12%
17. Congresses 12%
18. SARS Virus 12%
19. Interferons 11%
20. HIV Protease Inhibitors 11%
21. HIV-1 11%
22. Ribavirin 11%
23. Protease Inhibitors 11%
24. sofosbuvir drug combination ledipasvir 11%
25. dolutegravir 11%
26. BMS-790052 10%
27. Antiviral Agents 10%
28. Glycoproteins 10%
29. Nelfinavir 10%
30. TNF-Related Apoptosis-Inducing Ligand 10%
31. Tenofovir 10%
32. Cell Death 10%
33. Human Influenza 9%
34. Genotype 9%
35. Pandemics 9%
36. Chemokine Receptors 9%
37. Clinical Trials 8%
38. Ritonavir 8%
39. Viruses 8%
40. Hepatocytes 8%
41. Disinfectants 8%
42. Losartan 8%
43. Salvage Therapy 8%
44. Kidney 8%
45. Intravenous Immunoglobulins 7%
46. GS-5734 7%
47. asunaprevir 7%
48. Placebos 7%
49. ibalizumab 7%
50. bictegravir 6%